SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-307331
Filing Date
2022-12-16
Accepted
2022-12-16 16:10:20
Documents
13
Period of Report
2022-12-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d413893d8k.htm   iXBRL 8-K 26526
2 EX-3.1 d413893dex31.htm EX-3.1 168935
  Complete submission text file 0001193125-22-307331.txt   360827

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20221215.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20221215_lab.xml EX-101.LAB 19483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20221215_pre.xml EX-101.PRE 12146
7 EXTRACTED XBRL INSTANCE DOCUMENT d413893d8k_htm.xml XML 3674
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 221468057
SIC: 2836 Biological Products, (No Diagnostic Substances)